First drug for frostbite approved

Taking stock of the drug industry, from the lab to the medicine chest

February 16, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Jon Cherry/Getty Images STAT+ | For unlucky mountaineers, tundra explorers, and the unhoused, a new drug could avert the ravages of frostbite The newly FDA-approved infusion Aurlumyn (ilosprost) works by affecting blood flow, and in many cases has averted amputation. By Jason Mast STAT+ | Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech Security and competitiveness fears were aired by House select committee members. By Robert Weisman — Boston Globe STAT+ | Flagship Pioneering startup lays off a third of staff Sonata Therapeutics, a startup created two years ago through the merger of two Flagship companies, has laid off about a third of its staff. By Allison DeAngelis Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser